Benzoxazole kinase inhibitors and methods of use

Inventors: Pingda Ren (San Diego, CA); Yi Liu (San Diego, CA); Troy Edward Wilson (San Marino, CA); Liansheng Li (San Diego, CA); Katrina Chan (San Diego, CA)

Assignee: Intellikine, LLC

A61K31/519 A61K31/275 A61K31/337 A61K31/455 A61K31/5377 A61K31/7068 A61K39/3955 A61K45/06 C07D413/04 C07D413/14 C07D487/04 C07F5/025

View Patent ↗

Loading inventors, assignments & file history…

Monitor This Case

Get email alerts when status or documents change.

Order Certified Copies

Most orders are placed with the USPTO same day — all within 24 business hours.

Order via The Patent Place →

Pre-filled with this patent's details

Quick Facts

Patent No.: US 9,345,706
App. No.: 14/727,336
Granted: May 24, 2016
Kind: B2

External Links

USPTO Patent Center↗ Full Patent PDF↗

Abstract

The present invention provides chemical entities or compounds and pharmaceutical compositions thereof that are capable of modulating certain protein kinases such as mTor, tyrosine kinases, and/or lipid kinases such as PI3 kinase. Also provided in the present invention are methods of using these compositions to modulate activities of one or more of these kinases, especially for therapeutic applications.

Claims (2)

1. A pharmaceutical composition comprising a therapeutically effective amount of the following compound

or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier.

Assignments (5)

CHANGE OF NAME Recorded Jun 3, 2026

From: FAETH THERAPEUTICS, INC.

To: FAETH THERAPEUTICS, LLC

Reel/Frame 075821/0655 →

ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 5, 2023

From: CALITHERA BIOSCIENCES, INC.

To: FAETH THERAPEUTICS, INC.

Reel/Frame 064156/0744 →